PureHealth establishes a global Health Longevity Advisory Board to advance healthy ageing, AI-driven care, and evidence-based innovations across the Middle East.
PureHealth has launched a dedicated Health Longevity Advisory Board, bringing together globally recognised experts in health longevity science, medicine, and artificial intelligence. The board is set to play a pivotal role in advancing PureHealth’s mission to extend human healthspan and accelerate breakthroughs in healthy ageing.
It will oversee the strategic direction and clinical optimisation of the Pura Longevity Clinic, ensuring it aligns with global best practices. The board will also support the integration of cutting-edge tests, technologies, and scientific applications, while promoting a culture of research, innovation, and AI-driven patient care.
Beyond clinical guidance, the advisory board will provide input on research partnerships, clinician training, and the ethical adoption of emerging health longevity innovations throughout PureHealth’s network, ensuring that all interventions remain evidence-based and aligned with best practices.
Board members include Professor Brian Kennedy, Director of the Centre for Healthy Longevity at the National University of Singapore; Dr. Hinda Daggag, Executive Director of Longevity at PureHealth; Dr Ana Baroni, Chief Science Officer at LongevityTech.fund and Chief Medical Officer at HealthyLongevity.clinic in the United States; and Professor Eran Segal, Chair of Computational Biology at the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and Professor at the Weizmann Institute of Science.
Dr. Hinda Daggag, Executive Director of Longevity at PureHealth, said: “The establishment of the Health Longevity Advisory Board marks a critical milestone in our mission to transform health longevity science into accessible, personalised care. By uniting global experts in longevity medicine, genomics, and data science, the board will guide the scientific and clinical direction of the Clinic, ensuring every intervention is evidence-based, ethically applied, and tailored to individual biology. Their expertise will support advanced diagnostics, research collaborations and clinician training, helping position the clinic as a global leader in precision health.”
Professor Brian Kennedy said: “PureHealth’s investment in longevity science represents one of the most ambitious efforts globally to translate research into real-world health outcomes. By embedding cutting-edge science within clinical care and leveraging AI to personalise prevention, the UAE is taking a leading role in shaping the future of human healthspan.”
